GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savior Lifetec Corp (ROCO:4167) » Definitions » Debt-to-Revenue

Savior Lifetec (ROCO:4167) Debt-to-Revenue : 0.16 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Savior Lifetec Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Savior Lifetec's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$8 Mil. Savior Lifetec's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$170 Mil. Savior Lifetec's annualized Revenue for the quarter that ended in Dec. 2024 was NT$1,108 Mil. Savior Lifetec's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.16.


Savior Lifetec Debt-to-Revenue Historical Data

The historical data trend for Savior Lifetec's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savior Lifetec Debt-to-Revenue Chart

Savior Lifetec Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.55 0.64 0.26 0.15

Savior Lifetec Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.27 0.20 0.16 0.16

Competitive Comparison of Savior Lifetec's Debt-to-Revenue

For the Biotechnology subindustry, Savior Lifetec's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Savior Lifetec's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Savior Lifetec's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Savior Lifetec's Debt-to-Revenue falls into.


;
;

Savior Lifetec Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Savior Lifetec's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(8.201 + 169.584) / 1217.327
=0.15

Savior Lifetec's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(8.201 + 169.584) / 1107.76
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Savior Lifetec Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Savior Lifetec's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Savior Lifetec Business Description

Traded in Other Exchanges
N/A
Address
No. 29, Kezhong Road, Hsinchu Science Park, Zhunan Township, Miaoli, TWN, 350
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.

Savior Lifetec Headlines

No Headlines